Aprogen Biologics Inc. ((주)에이프로젠바이오로직스)
KOSPI Stock Code: 003060 | DART Corp Code: 00101044
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | Aprogen Biologics Inc. |
|---|---|
| Korean legal name | (주)에이프로젠바이오로직스 |
| Alternate names | 에이프로젠바이오로직스 |
| Market | KOSPI |
| Stock Code | 003060 |
| DART Corp Code | 00101044 |
| CEO | 김재섭, 김정출 |
| Business Registration No. | 2188100518 |
| Corporate Registration No. | 1101110036396 |
| Established Date | 1960-12-03 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 서울특별시 송파구 백제고분로 480 4층 (방이동, 풍문빌딩) |
| Homepage | https://www.aprogen-pharm.com/ |
| source_url | https://dart.fss.or.kr |
| verified_at | 2026-11-01T08:15:57.572Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320000881
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 73,226,140,158 | KRW 67,378,141,310 |
| Operating Income (영업이익) | KRW -60,354,664,385 | KRW -52,823,131,512 |
| Net Income (당기순이익) | KRW -168,296,872,201 | KRW -104,979,607,721 |
| Total Assets (자산총계) | KRW 586,992,600,346 | KRW 590,984,471,828 |
| Total Liabilities (부채총계) | KRW 309,425,651,987 | KRW 212,293,831,663 |
| Total Equity (자본총계) | KRW 277,566,948,359 | KRW 378,690,640,165 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-30 | 20261030000609 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 에이프로젠 |
2026-10-26 | 20261026000181 | Report on significant holdings of stocks, etc. (Short form) | 주식등의대량보유상황보고서(약식) | 이창순 |
2026-10-08 | 20261008000508 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 에이프로젠 |
2026-10-08 | 20261008800455 | Decision on Provision of Collateral for Others | 타인에대한담보제공결정 | 에이프로젠바이오로직스 |
2026-10-06 | 20261006800649 | Cautionary Notice on Investment Decision (Disclosure of KRX) (관리종목지정 우려 예고) | 투자유의안내 (관리종목지정 우려 예고) | 유가증권시장본부 |
2026-10-02 | 20261002000650 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 에이프로젠 |
2026-10-02 | 20261002000647 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 에이프로젠 |
2026-10-02 | 20261002801007 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 에이프로젠바이오로직스 |
2026-09-23 | 20260923800575 | Results of issuance (Voluntary Disclosure) | 유상증자또는주식관련사채등의발행결과(자율공시) | 에이프로젠바이오로직스 |
2026-09-23 | 20260923800503 | Decision on Cash Loan | 금전대여결정 | 에이프로젠바이오로직스 |
2026-09-23 | 20260923000418 | [Corrected description]Decision on Capital Increase with Consideration | [기재정정]주요사항보고서(유상증자결정) | 에이프로젠바이오로직스 |
2026-09-11 | 20260911000555 | [Corrected description]Decision on Capital Increase with Consideration | [기재정정]주요사항보고서(유상증자결정) | 에이프로젠바이오로직스 |
2026-09-11 | 20260911000499 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 에이프로젠 |
2026-09-03 | 20260903000316 | Decision on Capital Increase with Consideration | 주요사항보고서(유상증자결정) | 에이프로젠바이오로직스 |
2026-09-02 | 20260902000254 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 에이프로젠 |
2026-09-02 | 20260902000248 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 에이프로젠 |
2026-09-02 | 20260902000203 | Report on significant holdings of stocks, etc. (Short form) | 주식등의대량보유상황보고서(약식) | 이창순 |
2026-08-21 | 20260821000468 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 에이프로젠 |
2026-08-13 | 20260813001428 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 에이프로젠바이오로직스 |
2026-08-11 | 20260811000459 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 에이프로젠 |
Source & Disclaimer
source_url: https://dart.fss.or.kr | verified_at: 2026-11-01T08:15:57.572Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.